Viewing StudyNCT06183931

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 7:56 PM
Last Modification Date: 2024-10-26 @ 3:16 PM
Study NCT ID: NCT06183931
Status: RECRUITING
Last Update Posted: 2024-06-21
First Post: 2023-11-15
Brief Title: Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
Sponsor: Alexion Pharmaceuticals Inc
Organization: Alexion Pharmaceuticals Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Transthyretin Amyloid Cardiomyopathy
Keywords:
Name View
ATTR-CM View
Amyloid Depleter View
ALXN2220 View
Transthyretin Amyloid Cardiomyopathy View
Transthyretin amyloid ATTR View
Transthyretin TTR View
N-terminal pro b-type natriuretic peptide NT-proBNP View
NT-proBNP View
Amyloidosis View